Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Return on Invested Capital (ROIC) | 17.7% | 18.3% | 12.3% | 16.3% | 18.1% | 29.1% | 25.3% | 31.1% | 20.4% | 12.9% | 8.5% | 7.8% | 17.9% | (3.9%) | 22.7% | 6.6% | 3.2% | 10.7% | 11.2% | 22.6% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month Return on Invested Capital (ROIC) is 13.6%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Return on Invested Capital (ROIC) for Bristol-Myers Squibb Company have been 12.6% over the past three years, and 11.5% over the past five years.
As of today, Bristol-Myers Squibb Company's Return on Invested Capital (ROIC) is 13.6%, which is lower than industry median of 13.6%. It indicates that Bristol-Myers Squibb Company's Return on Invested Capital (ROIC) is Bad.